Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: A study of the effect of heat on intraperitoneal oxaliplatin using a murine model

Annals of Surgery

Volumn 254, Issue 1, 2011, Pages 138-144

  Piché, Nelson ^a   Leblond, François A ^a   Sidéris, Lucas ^a   Pichette, Vincent ^a   Drolet, Pierre ^a   Fortier, Louis Philippe ^a   Mitchell, Andrew ^a   Dubé, Pierre ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG EFFECT; GENERAL ANESTHESIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PERITONEUM; PORTAL VEIN BLOOD; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; TEMPERATURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE MODELS, ANIMAL; HOT TEMPERATURE; MALE; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 79959504578     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182193143     Document Type: Article

References (19)

1. Royal RE, Pingpank JF, Jr. Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum. Semin Oncol. 2008;35(2):183-191. (Pubitemid 351479211)
2. Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545-1550. (Pubitemid 35404323)
3. Verwaal VJ, Bruin S, Boot H, et al. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426-2432.
4. Sugarbaker PH. A curative approach to peritoneal carcinomatosis from colorectal cancer. Semin Oncol. 2005;32(6 Suppl 9):S68-73. (Pubitemid 43080920)
5. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134(5):1296-1310.
6. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573-584. (Pubitemid 47106628)
7. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5(4):219-228. (Pubitemid 38391217)
8. Elias D, El Otmany A, Bonnay M, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology. 2002;63(4):346-352. (Pubitemid 36151527)
9. Elias D, Matsuhisa T, Sideris L, et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol. 2004;15(10):1558-1565. (Pubitemid 39409748)
10. Elias D, Bonnay M, Puizillou JM, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002;13(2):267-272. (Pubitemid 34704979)
11. Elias D, Sideris L, Pocard M, et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol. 2004;15(5):781-785. (Pubitemid 38714740)
12. Rietbroek RC, van de Vaart PJ, Haveman J, et al. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol. 1997;123(1): 6-12. (Pubitemid 26414189)
13. Cao C, Yan TD, Black D, et al. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16(8): 2152-2165.
14. Bereder J-M, Sohili BK, Sutot-Vial N, et al. Concepts de base de la chimiohyperthermie intrapéritonéale. In: Élias D, Gilly FN, Glehen O, eds. et al. Carcinoses Péritonéales d'origine Digestive et Primitive. 110e congres Français de chirurgie: Wolters Kluwer France; 2008:17-39.
15. Pestieau SR, Belliveau JF, Griffin H, et al. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Surg Oncol. 2001;76(2):106-114.
16. Elias D, Sideris L, Baton O, et al. Traitement chirurgical à visée curatrice des carcinoses péritonéales. EMC - Chirurgie. 2004;1(1):67-78. (Pubitemid 43549952)
17. Sugarbaker PH. Building on a consensus. J Surg Oncol. 2008;98(4):215-216.
18. Bendavid Y, Leblond FA, Dube P. A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat. Med Sci Monit. 2005;11(1):BR1-5. (Pubitemid 40116387)
19. Graham MA, Lockwood GF, Greenslade D, et al. Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res. 2000;6(4):1205-1218. (Pubitemid 30226200)